PASG - Passage BIO, Inc.
8.4
0.280 3.333%
Share volume: 66,082
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$8.12
0.28
0.03%
Summary score
27%
Profitability
36%
Dept financing
16%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
14.79%
Return on assets
-9.65%
Return on sales
0%
Return on invested capital
631.03%
Total debt ratio
68.31%
Debt ratio change over timeo
0%
Current Ratio
63.24%
Quick Ratio
0%
Cash Position Ratio
54.83%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.78%
Return on assets
-6.47%
Return on sales
0%
Return on invested capital
49.68%
Total debt ratio
45.62%
Debt ratio change over timeo
0%
Current Ratio
48.06%
Quick Ratio
0%
Cash Position Ratio
46.11%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.48%
Return on assets
-7.22%
Return on sales
0%
Return on invested capital
636.79%
Total debt ratio
3.89%
Debt ratio change over time
0%
Current Ratio
26.05%
Quick Ratio
0%
Cash Position Ratio
25.01%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PASG | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 14.79% | 11.55% | 5.76% | 8.53% |
| Return on assets | -9.65% | 3.57% | 4.02% | 5.96% |
| Return on sales | 0% | 42.16% | 39.53% | 45.73% |
| Return on invested capital | 631.03% | 7.99% | 5.61% | 8.26% |
| Profitability | 50% | 58% | 48% | 65% |
| Total debt ratio | 68.31% | 74.11% | 65.71% | 48.2% |
| Debt ratio change over time | 0% | 0% | 376.49% | 4.51% |
| Dept financing | 23% | 25% | 47% | 17% |
| Current Ratio | 48.06% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 46.11% | 0.76% | 2.25% | 1% |
| Liquididy | 50% | 27% | 24% | 18% |
| Short-term ratios | PASG | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 3.78% | 17.94% | -1.29% | 11.66% |
| Return on assets | -6.47% | 3.67% | 1.51% | 6.9% |
| Return on sales | 0% | 37.5% | 16.39% | 50.72% |
| Return on invested capital | 49.68% | 7.17% | -0.65% | 10.66% |
| Profitability | 30% | 60% | 14% | 72% |
| Total debt ratio | 45.62% | 83.42% | 64.86% | 51.93% |
| Debt ratio change over time | 0% | 0% | 1.76% | 4.05% |
| Dept financing | 14% | 25% | 30% | 41% |
| Current Ratio | 48.06% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 46.11% | 0.76% | 2.25% | 1% |
| Liquididy | 50% | 17% | 28% | 17% |